Price target upside
Bristol-Myers Squibb Price Target: +6% vs Current Price
Direct answer
Bristol-Myers Squibb's analyst target implies +6%.
The average target is $65.25 compared with a recorded current price of $61.55.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 27, 2026.
Get free Bristol-Myers Squibb email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $61.55
- Average price target
- $65.25
- High price target
- $80.00
- Low price target
- $41.00
- Low target gap
- -33.4%
- Target upside
- +6%
- High target gap
- +30%
- Target range width
- 63.4%
- Consensus rating
- Buy
- Analysts
- 24
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Bristol-Myers Squibb's average target imply?
Bristol-Myers Squibb's average target is $65.25 versus a recorded price of $61.55. The difference is +6%.
How far are Bristol-Myers Squibb's low and high targets from the recorded price?
The low target implies -33.4%, while the high target implies +30%.
How many analysts are included in Bristol-Myers Squibb's consensus?
The verified consensus includes 24 analysts.
How is Bristol-Myers Squibb's target upside or downside calculated?
The average target of $65.25 is divided by the recorded price of $61.55, then one is subtracted to produce +6%. This does not guarantee a future return.
When was Bristol-Myers Squibb's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.